experspadmin

Expert Perspectives in Multiple Sclerosis to Cover Key Topics in Multiple Sclerosis Treatment
Neurology

Expert Perspectives in Multiple Sclerosis to Cover Key Topics in Multiple Sclerosis Treatment

expert perspectives
By Eric C. Klawiter, MD, MSc; Malcolm H. Gottesman, MD; Robert A. Bermel, MD, MBA
Evolving Role of Bruton Tyrosine Kinase Inhibitors and Novel Agents in Chronic Lymphocytic Leukemia
Oncology

Evolving Role of Bruton Tyrosine Kinase Inhibitors and Novel Agents in Chronic Lymphocytic Leukemia

expert roundtables
By Matthew S. Davids, MD, MMSc; William G. Wierda, MD, PhD
Personalized Treatment for Chronic Lymphocytic Leukemia: Therapeutic Sequencing and Novel Agents
Oncology

Personalized Treatment for Chronic Lymphocytic Leukemia: Therapeutic Sequencing and Novel Agents

expert roundtables
By Matthew S. Davids, MD, MMSc; William G. Wierda, MD, PhD
Options for Patients With Intolerance to First-Generation Bruton Tyrosine Kinase Inhibitor Therapy
Oncology

Options for Patients With Intolerance to First-Generation Bruton Tyrosine Kinase Inhibitor Therapy

patient care perspectives
By William G. Wierda, MD, PhD
Optimizing the Approach to Treatment-Naive Chronic Lymphocytic Leukemia
Oncology

Optimizing the Approach to Treatment-Naive Chronic Lymphocytic Leukemia

patient care perspectives
By Matthew S. Davids, MD, MMSc
Load More